Skip to main content

Korea’s quantum leap into the global pharma market (EN)

K-Pharm’s quantum leap into the global market: How Korea emerged as a pharmaceutical powerhouse along with K-Pop’s global invasion

First taking the globe by the storm with K-Pop and culture, Korea has now emerged as a strong player in the global pharmaceutical landscape. The Korean pharmaceutical industry not only holds diverse and enriched R&D pipelines, but also possesses a strong portfolio of stringent regulatory authority (SRA) approvals – an interesting market for European companies.

At this event, Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) will introduce the Korean pharmaceutical landscape and its unique strengths. Along with KPBMA, promising Korean pharmaceutical companies including Yuhan Corporation and Hanmi Pharmaceutical will discuss their R&D pipelines and areas for potential collaboration with European partners.

Join Basel Area Business & Innovation for an exceptional opportunity of networking with Korean pharmaceutical partners. This event is empowered by Innosuisse.



Door opening


Martyna Wroblewska, Basel Area Business & Innovation


Introduction KPBMA
Hyunwoo Lee, Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), Executive Director, International Affairs Department


Partnering with Yuhan Corporation
Han Kim, Yuhan Corporation, Regional Representative for Europe


Partnering with Hanmi Pharmaceutical
Young-Mi Lee, Hanmi Pharmaceutical, Senior Vice President, Head of Global R&D Innovation


Meet Korean pharma representatives: networking apéro

Participation is free, however registration is required before October 20th, 2022.